Lv4
760 积分 2023-10-13 加入
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma
24天前
已完结
Don't put the CART before the horse: The role of radiation therapy in peri-CAR T-cell therapy for aggressive B-cell non-Hodgkin lymphoma
1个月前
已完结
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
1个月前
已完结
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
1个月前
已完结
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
2个月前
已完结
Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome
2个月前
已完结
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients
3个月前
已完结
The promise and harms of screening for plasma cell dyscrasias
3个月前
已完结
Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease
3个月前
已完结
Next generation flow cytometry for MRD detection in patients with AL amyloidosis
3个月前
已完结
皖公网安备34019202002308
